Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel
Clinical trial NCT02961257 · COMPLETED
Trial details
- NCT number
- NCT02961257
- Sponsor
- Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2021-12-02
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.